Sort by
Refine Your Search
-
Applications are invited for the prestigious Eric and Wendy Schmidt AI in Science Fellowships, a program of Schmidt Sciences, commencing 1 September 2026. This 1-year appointment at Imperial College
-
The Biomedical Image Analysis Group, led by Prof Ben Glocker, in the Department of Computing at Imperial College London is seeking a talented Research Assistant / Associate to take a key role in an
-
, model predictive control, parallel computing using JAX and rapid online learning, is highly desirable, but candidates demonstrating an ability and willingness to become familiar with these topics and able
-
Applications are invited for the prestigious Eric and Wendy Schmidt AI in Science Fellowships, a program of Schmidt Sciences, commencing 1 September 2026. This 1-year appointment at Imperial College
-
The post of Research Associate (post-doctoral) will conduct research in data analysis and computational modelling of neuroimaging data, as part of a project titled “The Self, Unbound: Neurofeedback
-
Please note that job descriptions are not exhaustive, and you may be asked to take on additional duties that align with the key responsibilities mentioned above. We reserve the right to close the advert prior to the closing date stated should we receive a high volume of applications. It is...
-
sources, with strong potential for real-world applications in human-computer interaction, assistive technologies, embodied AI, and creative media generation. The posts will be based in the Department
-
environment for undergraduates, Masters and PhD students, as well as post-doctoral research fellows. You will be expected to bring or develop a research programme in bacterial/fungal infection biology. You will
-
radiances. Experience applying quantitative methods to Earth Observation datasets using a scientific computing programming language such as Python, IDL, MATLAB or equivalent is required. Demonstrable ability
-
Are you interested in using your computational biology skills to improve understanding of rare tumours and identifying biomarkers that will improve patient management? We are the world leaders in